United States

Profile: Anatara Lifesciences Ltd (ANR.AX)

ANR.AX on Australia Stock Exchange

26 Sep 2017
Change (% chg)

$-0.00 (-0.38%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Anatara Lifesciences Ltd is an Australia-based company focused on developing oral solutions for gastrointestinal diseases in production animals and humans and the development and commercialization of Detach, a non-antibiotic therapy that prevents and treats diarrhea (scour) in piglets. Detach is a modified release formulation of BromelainRx, a natural extract from pineapple stems. Detach helps in address the overuse of antibiotics in animals. It is formulated with various ingredients to allow oral administration and delivery to the small intestine. The Company is focused on developing Detach for pigs in Australia and then expanding the program to Europe and the United States. The Company is also developing a similar version of Detach to prevent diarrhea in humans. The Company is seeking to collaborate with pharmaceutical/biotechnology companies for clinical development and commercialization of a similar version of Detach for human application in travelers and military personnel.

Company Address

Anatara Lifesciences Ltd

Comsec Building, 433 Logan Rd
P: +617.33948202
F: +617.32299949

Company Web Links